These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL; JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257 [TBL] [Abstract][Full Text] [Related]
23. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. O'Donoghue M; Boden WE; Braunwald E; Cannon CP; Clayton TC; de Winter RJ; Fox KA; Lagerqvist B; McCullough PA; Murphy SA; Spacek R; Swahn E; Wallentin L; Windhausen F; Sabatine MS JAMA; 2008 Jul; 300(1):71-80. PubMed ID: 18594042 [TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial. Clemmensen P; Roe MT; Hochman JS; Cyr DD; Neely ML; McGuire DK; Cornel JH; Huber K; Zamoryakhin D; White HD; Armstrong PW; Fox KA; Prabhakaran D; Ohman EM; Am Heart J; 2015 Oct; 170(4):695-705.e5. PubMed ID: 26386793 [TBL] [Abstract][Full Text] [Related]
25. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial. Lopes RD; White JA; Tricoci P; White HD; Armstrong PW; Braunwald E; Giugliano RP; Harrington RA; Lewis BS; Brogan GX; Gibson CM; Califf RM; Newby LK Int J Cardiol; 2013 Sep; 167(6):2580-7. PubMed ID: 22795720 [TBL] [Abstract][Full Text] [Related]
26. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials. Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325 [TBL] [Abstract][Full Text] [Related]
27. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial. Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824 [TBL] [Abstract][Full Text] [Related]
28. Are Prior Aspirin Users With ST-Elevation Myocardial Infarction at Increased Risk of Adverse Events and Worse Angiographic Features? Geraiely B; Poorhosseini H; Sadeghian S; Sattarzadeh Badkoubeh R; Mortazavi SH Crit Pathw Cardiol; 2018 Dec; 17(4):208-211. PubMed ID: 30418251 [TBL] [Abstract][Full Text] [Related]
29. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. Parodi G; Marcucci R; Valenti R; Gori AM; Migliorini A; Giusti B; Buonamici P; Gensini GF; Abbate R; Antoniucci D JAMA; 2011 Sep; 306(11):1215-23. PubMed ID: 21934054 [TBL] [Abstract][Full Text] [Related]
30. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial. Berwanger O; Guimarães HP; Laranjeira LN; Cavalcanti AB; Kodama AA; Zazula AD; Santucci EV; Victor E; Tenuta M; Carvalho V; Mira VL; Pieper KS; Weber B; Mota LH; Peterson ED; Lopes RD; JAMA; 2012 May; 307(19):2041-9. PubMed ID: 22665103 [TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044 [TBL] [Abstract][Full Text] [Related]
33. Updates in antiplatelet agents used in cardiovascular diseases. Cheng JW J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):514-24. PubMed ID: 24213473 [TBL] [Abstract][Full Text] [Related]
34. Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST). Le May MR; Wells GA; Glover CA; So DY; Froeschl M; Marquis JF; O'Brien ER; Turek M; Thomas A; Kass M; Jadhav S; Labinaz M Circ Cardiovasc Interv; 2009 Aug; 2(4):330-8. PubMed ID: 20031736 [TBL] [Abstract][Full Text] [Related]
35. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. Roe MT; Armstrong PW; Fox KA; White HD; Prabhakaran D; Goodman SG; Cornel JH; Bhatt DL; Clemmensen P; Martinez F; Ardissino D; Nicolau JC; Boden WE; Gurbel PA; Ruzyllo W; Dalby AJ; McGuire DK; Leiva-Pons JL; Parkhomenko A; Gottlieb S; Topacio GO; Hamm C; Pavlides G; Goudev AR; Oto A; Tseng CD; Merkely B; Gasparovic V; Corbalan R; Cinteză M; McLendon RC; Winters KJ; Brown EB; Lokhnygina Y; Aylward PE; Huber K; Hochman JS; Ohman EM; N Engl J Med; 2012 Oct; 367(14):1297-309. PubMed ID: 22920930 [TBL] [Abstract][Full Text] [Related]
36. The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Amad H; Yan AT; Yan RT; Huynh T; Gore JM; Montalescot G; DeYoung JP; Gallo R; Rose B; Steg PG; Goodman SG; Can J Cardiol; 2012; 28(1):48-53. PubMed ID: 22112683 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. Yu J; Mehran R; Dangas GD; Claessen BE; Baber U; Xu K; Parise H; Fahy M; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW JACC Cardiovasc Interv; 2012 Dec; 5(12):1231-8. PubMed ID: 23257371 [TBL] [Abstract][Full Text] [Related]
38. Clinical outcome after acute coronary syndrome in Japanese patients: an observational cohort study. Nakamura M; Yamashita T; Yajima J; Oikawa Y; Ogasawara K; Sagara K; Kirigaya H; Koike A; Nagashima K; Ohtsuka T; Uejima T; Suzuki S; Sawada H; Aizawa T J Cardiol; 2010 Jan; 55(1):69-76. PubMed ID: 20122551 [TBL] [Abstract][Full Text] [Related]
39. Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study. Brener SJ; Maehara A; Mintz GS; Weisz G; de Bruyne B; Serruys PW; Stone GW J Invasive Cardiol; 2015 Dec; 27(12):536-41. PubMed ID: 26208378 [TBL] [Abstract][Full Text] [Related]
40. Japanese postmarketing surveillance of clopidogrel for patients with non-ST-segment-elevation acute coronary syndrome indicated for percutaneous coronary intervention (J-PLACE NSTE-ACS). Morino Y; Ako J; Kobayashi M; Nakamura M Cardiovasc Interv Ther; 2014 Apr; 29(2):123-33. PubMed ID: 24307536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]